Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study

被引：0
|
作者：
Lale Atahan
Ferah Yıldız
Mustafa Cengiz
Bunyamin Kaplan
Metin Özkan
Gozde Yazici
Mete Gündoğ
Ayfer Haydaroğlu
Aylin F. Korcum
Meriç Şengöz
Maktav Dinçer
Müge Akmansu
Kayıhan Engin
Mutlu Hayran
机构：
[1] Hacettepe University,Department of Radiation Oncology
[2] Erciyes University,Department of Radiation Oncology
[3] Ankara Education and Investigation Hospital of Ministry of Health,Department of Radiation Oncology
[4] Ege University,Department of Radiation Oncology
[5] Akdeniz University,Department of Radiation Oncology
[6] Marmara University,Department of Radiation Oncology
[7] İstanbul University,Department of Radiation Oncology
[8] Gazi University,Department of Radiation Oncology
[9] Uludağ University,Department of Radiation Oncology
[10] Anadolu Sağlık Merkezi,Department of Preventive Oncology
[11] Hacettepe University,undefined
来源：
Supportive Care in Cancer | 2010年 / 18卷
关键词：
Bone metastasis; Breast cancer; Radiotherapy; Zoledronic acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 698
页数：7
相关论文
共 50 条
  • [1] Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study
    Atahan, Lale
    Yildiz, Ferah
    Cengiz, Mustafa
    Kaplan, Bunyamin
    Ozkan, Metin
    Yazici, Gozde
    Gundog, Mete
    Haydaroglu, Ayfer
    Korcum, Aylin F.
    Sengoz, Meric
    Dincer, Maktav
    Akmansu, Muege
    Engin, Kayihan
    Hayran, Mutlu
    SUPPORTIVE CARE IN CANCER, 2010, 18 (06) : 691 - 698
  • [2] Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases:: A phase IV randomized study.
    Atahan, L.
    Yildiz, F.
    Cengiz, M.
    Kaplan, B.
    Ozkan, M.
    Haydaroglu, A.
    Sengoz, M.
    Korcums, A. F.
    Akmansu, M.
    Engin, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S524 - S525
  • [3] Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study.
    Atahan, I. L.
    Yildiz, F.
    Cengiz, M.
    Kaplan, B.
    Ozkan, M.
    Haydaroglu, A.
    Sengoz, M.
    Korcum, A. F.
    Akmansu, M.
    Engin, K.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S150 - S151
  • [4] Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study
    Stopeck, A.
    Body, J. J.
    Fujiwara, Y.
    Lipton, A.
    Steger, G. G.
    Viniegra, M.
    Fan, M.
    Braun, A.
    Dansey, R.
    Jun, S.
    EJC SUPPLEMENTS, 2009, 7 (03): : 2 - 3
  • [5] A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer
    Jacobs, C.
    Kuchuk, I.
    Bouganim, N.
    Smith, S.
    Mazzarello, S.
    Vandermeer, L.
    Dranitsaris, G.
    Dent, S.
    Gertler, S.
    Verma, S.
    Song, X.
    Simos, S.
    Cella, D.
    Clemons, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (01) : 77 - 84
  • [6] A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer
    C. Jacobs
    I. Kuchuk
    N. Bouganim
    S. Smith
    S. Mazzarello
    L. Vandermeer
    G. Dranitsaris
    S. Dent
    S. Gertler
    S. Verma
    X. Song
    S. Simos
    D. Cella
    M. Clemons
    Breast Cancer Research and Treatment, 2016, 155 : 77 - 84
  • [7] A double-blind randomized Study of Denosumab compared with Zoledronic acid for Treatment of Bone metastases in Patients with Breast cancer: Results of a randomized phase 3 study.
    Steger, G.
    Stopeck, A.
    Body, J. J.
    Fujiwara, Y.
    Lipton, A.
    Viniegra, M.
    Fan, M.
    Braun, A.
    Dansey, R.
    Jun, S.
    ONKOLOGIE, 2010, 33 : 10 - 10
  • [8] Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
    Stopeck, Alison T.
    Lipton, Allan
    Body, Jean-Jacques
    Steger, Guenther G.
    Tonkin, Katia
    de Boer, Richard H.
    Lichinitser, Mikhail
    Fujiwara, Yasuhiro
    Yardley, Denise A.
    Viniegra, Maria
    Fan, Michelle
    Jiang, Qi
    Dansey, Roger
    Jun, Susie
    Braun, Ada
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (35) : 5132 - 5139
  • [9] Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance
    Zhao, Xinmin
    Xu, Xiaofeng
    Guo, Lin
    Ragaz, Joseph
    Guo, Haiyi
    Wu, Jiong
    Shao, Zhimin
    Zhu, Ji
    Guo, Xiaomao
    Chen, Jiayi
    Zhu, Beiling
    Wang, Zhonghua
    Hu, Xichun
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (03) : 733 - 743
  • [10] Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance
    Xinmin Zhao
    Xiaofeng Xu
    Lin Guo
    Joseph Ragaz
    Haiyi Guo
    Jiong Wu
    Zhimin Shao
    Ji Zhu
    Xiaomao Guo
    Jiayi Chen
    Beiling Zhu
    Zhonghua Wang
    Xichun Hu
    Breast Cancer Research and Treatment, 2010, 124 : 733 - 743
12345